Procedure

Specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland

2023/0064(COD)·9th term·ENVI·COD - Ordinary legislative procedure (ex-codecision procedure)·CompletedProcedure completed

Subjects: Pharmaceutical products and industry

Rapporteur (the Member appointed to lead Parliament's work on this text): CANFIN Pascal (Renew)

Summary

A legislative proposal on specific rules for medicinal products for human use intended for the market of Northern Ireland. Amendments address the prohibition on displaying certain safety features, except anti-tampering device measures, on the packaging of those products, their removal or covering, the role of the qualified person and record-keeping, authorisation of new and innovative products by United Kingdom competent authorities, and the conditions and written guarantees required.

Procedure timeline

Committee amendments tabled
12 Apr 2023
Plenary vote — Passed
9 May 2023 · On the Commission proposal (the draft law)
Procedure completed

Amendments

distinct, in window

Members

tabled at least one

Committee(s)

12 Apr 2023

Dates

Plenary votes

1 roll-call votes

In plenary, Parliament usually votes in steps: first on amendments to the text (sometimes split into parts, so Members can accept one half of a sentence and reject the other), then on the text as a whole. The “main vote” is the one that adopts or rejects the text itself. Each vote below shows exactly which step it was. How voting works →

9 May 2023Main votePassedoutcome from totals
On the Commission proposal (the draft law)
Official label: Proposition de la Commission · what was voted ↗
617 for3 against6 abstentions79 did not vote
For
Against
Abst.
Click a group to see each Member’s position.